For Drug Corporations, Aiding the Sick and Poor Is Bad Business

A simply-worded headline in Monday’s New York Times crystallizes the often ignored tension between the proliferation of disease among the global poor and the interests of the for-profit pharmaceutical industry by declaring: “India’s Efforts to Aid Poor Worry Drug Makers.”

As the Times reports—much to the chagrin of the “business groups, legislators and drug makers in the United States”— India has increasingly challenged patent protections in order to care for their impoverished population by allowing the production of less costly, generic versions of numerous drugs.

Read more »

Advertisements

About lightsigns
Pointing my finger on the brighter spots. We win, and winning is fun.

Comments are closed.

%d bloggers like this: